Suppr超能文献

体内皮质微结构:与老年人 Tau 蛋白病及认知障碍的关系

In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly.

作者信息

Schifani Christin, Anderson John A E, Nazeri Arash, Voineskos Aristotle N

机构信息

Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

Department of Cognitive Science, Carleton University, Ottawa, Canada.

出版信息

J Neurochem. 2025 Aug;169(8):e70167. doi: 10.1111/jnc.70167.

Abstract

Positron Emission Tomography (PET) of tau is considered "the" indicator of Alzheimer's pathology. However, non-PET proxies would be helpful for wider accessibility. We used Neurite Orientation Dispersion and Density Imaging (NODDI)-derived indices (i.e., orientation dispersion [ODI], neurite density [NDI], and free-water [fISO]) to determine relationships of gray matter microstructure with tau and cognitive impairment. We assessed the fit between NODDI indices, cortical thickness/subcortical volume (CT/ScVol), and tau via multiple factor analysis (MFA) using data from 80 participants from the ADNI-3 dataset with overlapping multishell diffusion-weighted and tau-PET scans ([F]AV-1451); 49 were considered cognitively normal older adults (age ~74 years), 26 were diagnosed with mild cognitive impairment (age ~75 years), and five had Alzheimer's dementia (age ~78 years). fISO and tau shared a large amount of spatial overlap, and both strongly correlated with the first MFA dimension. Macrostructural features (i.e., CT/ScVol) were 7% less related to this first MFA dimension than fISO and 8% less than tau. Subsequent mediation analyses demonstrated that fISO mediated the relationship between CT/ScVol and tau, explaining all of the variance. Our results suggest that microstructural features derived from NODDI such as fISO might be useful adjunct markers to tau, which needs to be confirmed in longitudinal studies. Cortical fISO, rather than macrostructure (i.e., CT/ScVol), may represent tau's impact on the brain (and, by extension, cognition).

摘要

正电子发射断层扫描(PET)检测tau蛋白被认为是阿尔茨海默病病理学的“金标准”指标。然而,非PET替代指标将有助于更广泛的应用。我们使用神经突方向离散度和密度成像(NODDI)衍生指标(即方向离散度[ODI]、神经突密度[NDI]和自由水[fISO])来确定灰质微观结构与tau蛋白及认知障碍之间的关系。我们通过多因素分析(MFA)评估了NODDI指标、皮质厚度/皮质下体积(CT/ScVol)和tau蛋白之间的拟合度,使用的数据来自阿尔茨海默病神经成像计划-3(ADNI-3)数据集的80名参与者,这些参与者同时进行了多壳层扩散加权扫描和tau蛋白PET扫描([F]AV-1451);其中49名被认为是认知正常的老年人(年龄约74岁),26名被诊断为轻度认知障碍(年龄约75岁),5名患有阿尔茨海默病痴呆(年龄约78岁)。fISO和tau蛋白在空间上有大量重叠,且二者均与第一个MFA维度高度相关。宏观结构特征(即CT/ScVol)与第一个MFA维度的相关性比fISO低7%,比tau蛋白低8%。随后的中介分析表明,fISO介导了CT/ScVol与tau蛋白之间的关系,解释了所有的方差。我们的结果表明,源自NODDI的微观结构特征(如fISO)可能是tau蛋白的有用辅助标志物,这需要在纵向研究中得到证实。皮质fISO,而非宏观结构(即CT/ScVol),可能代表了tau蛋白对大脑(进而对认知)的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验